Stakeholder committee evaluation report (1)

Timely communication among the various stakeholders is critical to ensure patient safety in clinical trials. In order to spread awareness and information about the project and its results beyond the research community with the public as a whole, we envisage to install a stakeholder committee that will consist of experts from major interest groups that are interested in receiving exposure to the project and are willing to exchange knowledge relating to ReSToRe’s communication and operation, i.e. representatives from patient organizations (including patients and their families), the investigators, institutional review board/ethics committee, and the scientific, medical and business community. The stakeholder committee will be informed regularly per e-mail and in organized meetings about the progress of the project and will supervise the research and the dissemination material. On the other hand, the members of the stakeholder committee will provide the project with an opportunity to receive external validation of approach and results, whilst supporting networks and associations thereby amplifying the outreach of ReStoRe’s dissemination plan. By involving the stakeholder committee from the start to the end of the project, we will ensure a high quality level of all actions.